Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Becton Dickinson and Company (BDX)

Becton Dickinson and Company (BDX)
201.39 x 100 218.61 x 100
Post-market by (Cboe BZX)
204.45 +2.13 (+1.05%) 04/24/25 [NYSE]
201.39 x 100 218.61 x 100
Post-market 204.45 unch (unch) 17:22 ET
Profile for Thu, Apr 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Becton Dickinson and Company ONE BECTON DRIVE FRANKLIN LAKES NJ 07417 USA

www.bd.com Employees: 74,000 P: 201-847-6800

Sector:

Medical

Description:

Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.

Key Statistics

Overview:

Market Capitalization, $K 58,093,156
Enterprise Value, $K 74,177,152
Shares Outstanding, K 287,135
Annual Sales, $ 20,178 M
Annual Net Income, $ 1,705 M
Last Quarter Sales, $ 5,168 M
Last Quarter Net Income, $ 303,000 K
EBIT, $ 2,414 M
EBITDA, $ 4,700 M
60-Month Beta 0.35
% of Insider Shareholders 0.36%
% of Institutional Shareholders 86.97%
Float, K 286,101
% Float 99.64%
Short Volume Ratio 0.51

Growth:

1-Year Return -12.56%
3-Year Return -17.29%
5-Year Return -18.83%
5-Year Revenue Growth 16.70%
5-Year Earnings Growth 12.50%
5-Year Dividend Growth 23.38%

Per-Share Information:

Most Recent Earnings 3.43 on 02/05/25
Next Earnings Date 05/01/25 [BMO]
Earnings Per Share ttm 13.91
EPS Growth vs. Prev Qtr -9.97%
EPS Growth vs. Prev Year 27.99%
Annual Dividend Rate, $ 3.98
Annual Dividend Yield 1.97%
Most Recent Dividend 1.040 on 03/10/25
Next Ex-Dividends Date 03/10/25
Dividend Payable Date 03/31/25
Dividend Payout Ratio 27.79%
Most Recent Split 2-1 on 08/21/98

BDX Ratios

Ratio
Price/Earnings ttm 14.37
Price/Earnings forward 13.86
Price/Earnings to Growth 1.44
Return-on-Equity % 15.75%
Return-on-Assets % 7.29%
Profit Margin % 8.45%
Debt/Equity 0.69
Price/Sales 2.84
Price/Cash Flow 9.46
Price/Book 2.28
Book Value/Share 87.78
Interest Coverage 4.80

BDX Dividends

Date Value
03/10/25 $1.0400
12/09/24 $1.0400
09/09/24 $0.9500
06/10/24 $0.9500
03/07/24 $0.9500
12/07/23 $0.9500
09/07/23 $0.9100
06/08/23 $0.9100
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective